These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 27514776

  • 1. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
    Inatomi N, Matsukawa J, Sakurai Y, Otake K.
    Pharmacol Ther; 2016 Dec; 168():12-22. PubMed ID: 27514776
    [Abstract] [Full Text] [Related]

  • 2. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K, Carlsson E.
    Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
    [Abstract] [Full Text] [Related]

  • 3. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.
    Yang X, Li Y, Sun Y, Zhang M, Guo C, Mirza IA, Li YQ.
    Dig Dis Sci; 2018 Feb; 63(2):302-311. PubMed ID: 29282636
    [Abstract] [Full Text] [Related]

  • 4. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review.
    Patel A, Laine L, Moayyedi P, Wu J.
    Gastroenterology; 2024 Nov; 167(6):1228-1238. PubMed ID: 39269391
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers].
    Choi YJ.
    Korean J Gastroenterol; 2022 Dec 25; 80(6):247-253. PubMed ID: 36567437
    [Abstract] [Full Text] [Related]

  • 6. Acid suppression therapy: where do we go from here?
    Scarpignato C, Pelosini I, Di Mario F.
    Dig Dis; 2006 Dec 25; 24(1-2):11-46. PubMed ID: 16699262
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun 25; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 9. [New trends of acid-related diseases treatment].
    Koike T, Nakagawa K, Kanno T, Iijima K, Shimosegawa T.
    Nihon Rinsho; 2015 Jul 25; 73(7):1136-46. PubMed ID: 26165070
    [Abstract] [Full Text] [Related]

  • 10. Vonoprazan fumarate for the management of acid-related diseases.
    Martinucci I, Blandizzi C, Bodini G, Marabotto E, Savarino V, Marchi S, de Bortoli N, Savarino E.
    Expert Opin Pharmacother; 2017 Aug 25; 18(11):1145-1152. PubMed ID: 28657473
    [Abstract] [Full Text] [Related]

  • 11. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments.
    Scarpignato C, Hunt RH.
    Curr Gastroenterol Rep; 2024 Nov 25; 26(11):273-293. PubMed ID: 39145848
    [Abstract] [Full Text] [Related]

  • 12. Novel approaches to inhibition of gastric acid secretion.
    Sachs G, Shin JM, Hunt R.
    Curr Gastroenterol Rep; 2010 Dec 25; 12(6):437-47. PubMed ID: 20924727
    [Abstract] [Full Text] [Related]

  • 13. The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations.
    Echizen H.
    Clin Pharmacokinet; 2016 Apr 25; 55(4):409-18. PubMed ID: 26369775
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 Apr 25; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Control of gastric acid secretion in health and disease.
    Schubert ML, Peura DA.
    Gastroenterology; 2008 Jun 25; 134(7):1842-60. PubMed ID: 18474247
    [Abstract] [Full Text] [Related]

  • 18. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis.
    Simadibrata DM, Syam AF, Lee YY.
    J Gastroenterol Hepatol; 2022 Dec 25; 37(12):2217-2228. PubMed ID: 36181401
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).
    Otake K, Sakurai Y, Nishida H, Fukui H, Tagawa Y, Yamasaki H, Karashima M, Otsuka K, Inatomi N.
    Adv Ther; 2016 Jul 25; 33(7):1140-57. PubMed ID: 27287852
    [Abstract] [Full Text] [Related]

  • 20. Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents.
    Sanders SW.
    Clin Ther; 1996 Jul 25; 18(1):2-34; discussion 1. PubMed ID: 8851451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.